相关实验视频

Updated: May 31, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

针对肝纤维化的小分子设计策略的最新进展

Heming Chen¹, Wei Su¹, Tingting Li¹

¹School of Medicine, Shanghai University, Shanghai, 200444, China.

European journal of medicinal chemistry

|January 24, 2025

概括

本综述探讨了旨在对抗肝纤维化 - - 一种可逆性肝病 - - 的小分子药物. 它详细介绍了开发用于治疗肝病的新型抗纤维菌剂的策略.

科学领域:

肝病学肝病学是一种肝病学.
药用化学医学化学
药物发现药物发现药物发现

背景情况:

肝纤维化是各种肝脏疾病中常见的病理过程.
它被认为是一种潜在的可逆性疾病.
重要的研究重点是开发药物来逆转或阻断肝纤维化.

研究的目的:

审查用于抗肝纤维化治疗的小分子药物的设计策略.
为开发新型抗纤维菌剂提供见解.

主要方法:

该综述综合了各种类型的抗肝纤维化剂的信息.
它涵盖核受体配体 (VDR,Nurr7),激酶抑制剂 (ALK5,JAK1) 和PDE抑制剂.
它还讨论了来自自然产品的小分子和其他新的小分子.

主要成果:

已开发出有效的小分子药物,针对肝纤维化.
在制造抗纤维菌剂方面,各种设计策略已经被证明是成功的.
审查的药物代表了对抗肝纤维化的多种机制.

结论:

该审查强调了开发新抗肝纤维化药物的有希望的途径.
它为肝病治疗领域的研究人员提供了宝贵的见解.
继续开发小分子药物具有治疗肝纤维化的潜力.

关键词:

设计策略设计策略肝脏纤维化肝脏纤维化小分子分子小分子分子

更多相关视频

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Published on: May 19, 2018

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration

Published on: May 13, 2016

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...